REFERENCES BIBLIOGRAPHIQUES
~ 44 ~
[71]TOMIHATA, K. AND IKADA, Y. (1997). "In vitro and in vivo degradation of films of chitins and
its partially deacetylated derivatives." Biomaterials. Tom 18. pp 567-575.
[72]DENUZIÈRE et al. (1998). "Chitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte
complex: biological properties." Biomaterials. 19 p.
[73]Lahiti et al. (2000). "Chitosan supports the expression of extracellular matrix proteins in human
osteoblast and chondrocytes." Journal of Biomedical Materials Research. 51 p.
[74]CID et al. (2000). "Preparation and characterization of chitosan films: application in cell cultures".
Tom 4. pp 93-97.
[75]RAMOS V., GARCIA-CANTELAJO J. M., HERAS A. AND LOPEZ-LACOMBA J. L. (2000).
"Chitosan influence on the growth of several cellular lines". Tom 4. pp 194-199.
[76]MALETTE, W.G. AND QUIGLEY, H. J. (1985). "Method of achieving hemostasis, inhibiting
fibroplasia and promoting tissue regeneration in a tissue wound ". Brevet USA n°US4532134
[77]KLOKKEVOLD et al. (1999). "The effect of chitosan (poly-N-Acetyl-glucosamine) on lingual
hemostasis in heparinized rabbits." J. Oral Maxillofc. Surg. pp 49-52.
[78]RAO, S. B. AND SHARMA, C. P. (1997). "Use of the chitosane as a biomaterial: studies on its
safety and hemostatic potential." Journal of Biomedical Materials Research. Tom 34. pp 21-28.
[79]LEE, K. Y., HA, W. S. AND PARK, W. H. (1995). "Blood compatibility and biodegradability of
partially N-acetylated chitosan derivatives." Biomaterials. Tom 16. pp 1211-1216.
[80] DANIEL et al. (1992). Dictionnaire de dermatologie. Paris.
[81]ORTONNE, J.P. (1996). Anomalies de la pigmentation cutanée, in Traité de médecine, M.S.
Flammarion. Paris. pp 731-737.
[82]CHEN, C. -S., W.-Y. LIAU AND G. -J. TSAI. (1998). Antimicrobial effects of N-Sulfonated and
N-Sulfobenzoyl chitosan and application to oyster preservation. J. Food Protect. pp 1124-1128.
[83]HELANDER et al. (2001). Chitosan disrupts the barrier properties of the outer membrane of Gramnegative bacteria. Int. J. Food Microb. pp 235-244.
[84]TSAI, G.-J., SU, W. -H. (1999). Antimicrobial activity of shrimp chitosan against Escherichia coli.
J. Food Protect. pp 239-243.
[85]LIU, L. S. LI, H. GARREAU, AND M. VERT. (2000). Selective enzymatic degradations of poly
(L-lactide) and poly (ε-caprolactone) blend films. Biomacromol. pp 350-359.
[86]RABEA et al. (2003). Chitosan as antimicrobial agent: applications and mode of action.
Biomacromol. pp 1457-1465.
[87] LE DEVEDEC, F. (2008). Séparation des oligomères du chitosane par chromatographie d'affinité
sur ions métalliques immobilisés. Université du Québec, Montréal, Canada.
[88]KO et al. (1997). "Miscibility of chitosans/polyamide 6 blends". PolymerJournal. pp 997-1001.
[89]LE TIEN et al (2003). "N-acylated chitosan: hydrophobie matrices for controlled drug release".
Journal of Controlled Release. pp 1-13.
~ 44 ~
[71]TOMIHATA, K. AND IKADA, Y. (1997). "In vitro and in vivo degradation of films of chitins and
its partially deacetylated derivatives." Biomaterials. Tom 18. pp 567-575.
[72]DENUZIÈRE et al. (1998). "Chitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte
complex: biological properties." Biomaterials. 19 p.
[73]Lahiti et al. (2000). "Chitosan supports the expression of extracellular matrix proteins in human
osteoblast and chondrocytes." Journal of Biomedical Materials Research. 51 p.
[74]CID et al. (2000). "Preparation and characterization of chitosan films: application in cell cultures".
Tom 4. pp 93-97.
[75]RAMOS V., GARCIA-CANTELAJO J. M., HERAS A. AND LOPEZ-LACOMBA J. L. (2000).
"Chitosan influence on the growth of several cellular lines". Tom 4. pp 194-199.
[76]MALETTE, W.G. AND QUIGLEY, H. J. (1985). "Method of achieving hemostasis, inhibiting
fibroplasia and promoting tissue regeneration in a tissue wound ". Brevet USA n°US4532134
[77]KLOKKEVOLD et al. (1999). "The effect of chitosan (poly-N-Acetyl-glucosamine) on lingual
hemostasis in heparinized rabbits." J. Oral Maxillofc. Surg. pp 49-52.
[78]RAO, S. B. AND SHARMA, C. P. (1997). "Use of the chitosane as a biomaterial: studies on its
safety and hemostatic potential." Journal of Biomedical Materials Research. Tom 34. pp 21-28.
[79]LEE, K. Y., HA, W. S. AND PARK, W. H. (1995). "Blood compatibility and biodegradability of
partially N-acetylated chitosan derivatives." Biomaterials. Tom 16. pp 1211-1216.
[80] DANIEL et al. (1992). Dictionnaire de dermatologie. Paris.
[81]ORTONNE, J.P. (1996). Anomalies de la pigmentation cutanée, in Traité de médecine, M.S.
Flammarion. Paris. pp 731-737.
[82]CHEN, C. -S., W.-Y. LIAU AND G. -J. TSAI. (1998). Antimicrobial effects of N-Sulfonated and
N-Sulfobenzoyl chitosan and application to oyster preservation. J. Food Protect. pp 1124-1128.
[83]HELANDER et al. (2001). Chitosan disrupts the barrier properties of the outer membrane of Gramnegative bacteria. Int. J. Food Microb. pp 235-244.
[84]TSAI, G.-J., SU, W. -H. (1999). Antimicrobial activity of shrimp chitosan against Escherichia coli.
J. Food Protect. pp 239-243.
[85]LIU, L. S. LI, H. GARREAU, AND M. VERT. (2000). Selective enzymatic degradations of poly
(L-lactide) and poly (ε-caprolactone) blend films. Biomacromol. pp 350-359.
[86]RABEA et al. (2003). Chitosan as antimicrobial agent: applications and mode of action.
Biomacromol. pp 1457-1465.
[87] LE DEVEDEC, F. (2008). Séparation des oligomères du chitosane par chromatographie d'affinité
sur ions métalliques immobilisés. Université du Québec, Montréal, Canada.
[88]KO et al. (1997). "Miscibility of chitosans/polyamide 6 blends". PolymerJournal. pp 997-1001.
[89]LE TIEN et al (2003). "N-acylated chitosan: hydrophobie matrices for controlled drug release".
Journal of Controlled Release. pp 1-13.